Wird geladen...
Low-dose steroid-induced tumor lysis syndrome in a hepatocellular carcinoma patient
Tumor lysis syndrome is rare in hepatocellular carcinoma (HCC), but it has been reported more frequently recently in response to treatments such as transcatheter arterial chemoembolization (TACE), radiofrequency thermal ablation (RFTA), and sorafenib. Tumor lysis syndrome induced by low-dose steroid...
Gespeichert in:
| Veröffentlicht in: | Clin Mol Hepatol |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
The Korean Association for the Study of the Liver
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4379202/ https://ncbi.nlm.nih.gov/pubmed/25834806 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2015.21.1.85 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|